Literature DB >> 28097522

Severe Aortic Valve Stenosis in Adults is Associated with Increased Levels of Circulating Intermediate Monocytes.

Bernd Hewing1,2,3, Sebastian Chi-Diep Au4,5, Antje Ludwig4,5, Rena Ellerbroek4, Phillip van Dijck4, Lisa Hartmann6,7, Herko Grubitzsch8, Carolin Giannini9, Michael Laule4, Verena Stangl4,5, Gert Baumann4, Karl Stangl4,5.   

Abstract

Individual monocyte subsets have been associated with atherosclerotic disease, but their distribution has not been evaluated in aortic valve stenosis (AS) so far. In the present study, we have asked whether levels of the circulating intermediate monocyte subset are increased in AS. Classical (CD14++CD16-), intermediate (CD14++CD16+), and non-classical (CD14+CD16++) CD86-positive monocytes and monocyte activation (intensity of CD11b expression) were determined by flow cytometry in peripheral blood of patients with severe AS (n = 100) and matched AS-free controls (n = 75). AS patients exhibited significantly higher levels of circulating intermediate monocytes, while levels of circulating classical and non-classical monocytes or monocyte activation did not differ compared to controls. The difference in levels of intermediate monocytes between groups was independent of age, gender, BMI, LDL-C, NT-proBNP, NYHA functional class, or creatinine levels. The present pilot study provides evidence of an association of severe AS with increased levels of circulating intermediate monocytes. Further studies need to clarify whether this finding is related to the inflammatory status and hemodynamic disturbances associated with severe AS.

Entities:  

Keywords:  Aortic valve stenosis; Inflammation; Monocyte subsets

Mesh:

Substances:

Year:  2017        PMID: 28097522     DOI: 10.1007/s12265-016-9726-9

Source DB:  PubMed          Journal:  J Cardiovasc Transl Res        ISSN: 1937-5387            Impact factor:   4.132


  39 in total

Review 1.  Monocyte heterogeneity in human cardiovascular disease.

Authors:  Adam M Zawada; Kyrill S Rogacev; Stephan H Schirmer; Martina Sester; Michael Böhm; Danilo Fliser; Gunnar H Heine
Journal:  Immunobiology       Date:  2012-07-25       Impact factor: 3.144

2.  Time course of C-reactive protein, tumour necrosis factor-alpha and monocyte chemoattractant protein-1 following the surgical treatment of patients with aortic valve stenosis.

Authors:  Stylianos S Kastellanos; Ioannis K Toumpoulis; Constadina Aggeli; Stefanos Zezas; Emmanouil Chlapoutakis; Stamatis Kastellanos; Christodoulos I Stefanadis
Journal:  Hellenic J Cardiol       Date:  2007 Jan-Feb

3.  C-reactive protein is increased in patients with degenerative aortic valvular stenosis.

Authors:  A Galante; A Pietroiusti; M Vellini; P Piccolo; G Possati; M De Bonis; R L Grillo; C Fontana; C Favalli
Journal:  J Am Coll Cardiol       Date:  2001-10       Impact factor: 24.094

4.  Clinical factors, but not C-reactive protein, predict progression of calcific aortic-valve disease: the Cardiovascular Health Study.

Authors:  Gian M Novaro; Ronit Katz; Ronnier J Aviles; John S Gottdiener; Mary Cushman; Bruce M Psaty; Catherine M Otto; Brian P Griffin
Journal:  J Am Coll Cardiol       Date:  2007-10-29       Impact factor: 24.094

Review 5.  Calcific aortic stenosis: a disease of the valve and the myocardium.

Authors:  Marc R Dweck; Nicholas A Boon; David E Newby
Journal:  J Am Coll Cardiol       Date:  2012-10-10       Impact factor: 24.094

6.  Effect of aortic valve replacement on c-reactive protein in nonrheumatic aortic stenosis.

Authors:  Ivor L Gerber; Ralph A H Stewart; Christopher J K Hammett; Malcolm E Legget; Helen Oxenham; Teena M West; John K French; Harvey D White
Journal:  Am J Cardiol       Date:  2003-11-01       Impact factor: 2.778

7.  Monocyte and macrophage differentiation: circulation inflammatory monocyte as biomarker for inflammatory diseases.

Authors:  Jiyeon Yang; Lixiao Zhang; Caijia Yu; Xiao-Feng Yang; Hong Wang
Journal:  Biomark Res       Date:  2014-01-07

8.  Mast cells in human stenotic aortic valves are associated with the severity of stenosis.

Authors:  E Wypasek; J Natorska; G Grudzień; G Filip; J Sadowski; A Undas
Journal:  Inflammation       Date:  2013-04       Impact factor: 4.092

9.  M1/M2 macrophages and associated mechanisms in congenital bicuspid aortic valve stenosis.

Authors:  Rui Wang; Wen Chen; Zhifei Ma; Liangpeng Li; Xin Chen
Journal:  Exp Ther Med       Date:  2014-02-10       Impact factor: 2.447

10.  Serum and tissue biomarkers in aortic stenosis.

Authors:  Alkistis Kapelouzou; Loukas Tsourelis; Loukas Kaklamanis; Dimitrios Degiannis; Nektarios Kogerakis; Dennis V Cokkinos
Journal:  Glob Cardiol Sci Pract       Date:  2015-11-13
View more
  6 in total

Review 1.  Innate and adaptive immunity: the understudied driving force of heart valve disease.

Authors:  Francesca Bartoli-Leonard; Jonas Zimmer; Elena Aikawa
Journal:  Cardiovasc Res       Date:  2021-11-22       Impact factor: 10.787

2.  Interleukin 38 alleviates aortic valve calcification by inhibition of NLRP3.

Authors:  Erlinda The; Dennis M de Graaf; Yufeng Zhai; Qingzhou Yao; Lihua Ao; David A Fullerton; Charles A Dinarello; Xianzhong Meng
Journal:  Proc Natl Acad Sci U S A       Date:  2022-08-29       Impact factor: 12.779

Review 3.  Innate immune cells in the pathophysiology of calcific aortic valve disease: lessons to be learned from atherosclerotic cardiovascular disease?

Authors:  Wieteke Broeders; Siroon Bekkering; Saloua El Messaoudi; Leo A B Joosten; Niels van Royen; Niels P Riksen
Journal:  Basic Res Cardiol       Date:  2022-05-17       Impact factor: 12.416

Review 4.  Circulating Monocyte Subsets and Transcatheter Aortic Valve Replacement.

Authors:  Fanny Lassalle; Mickael Rosa; Bart Staels; Eric Van Belle; Sophie Susen; Annabelle Dupont
Journal:  Int J Mol Sci       Date:  2022-05-10       Impact factor: 6.208

Review 5.  Uncoupling the Vicious Cycle of Mechanical Stress and Inflammation in Calcific Aortic Valve Disease.

Authors:  Nalin H Dayawansa; Sara Baratchi; Karlheinz Peter
Journal:  Front Cardiovasc Med       Date:  2022-03-09

Review 6.  New Insights into the Roles of Monocytes/Macrophages in Cardiovascular Calcification Associated with Chronic Kidney Disease.

Authors:  Lucie Hénaut; Alexandre Candellier; Cédric Boudot; Maria Grissi; Romuald Mentaverri; Gabriel Choukroun; Michel Brazier; Saïd Kamel; Ziad A Massy
Journal:  Toxins (Basel)       Date:  2019-09-12       Impact factor: 4.546

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.